Dr Koen Pouwels
Koen joined HERC as a senior researcher in January 2019. His current work focuses on infectious disease and antimicrobial resistance modelling, randomised trial designs, economic evaluations alongside trials, incorporating long-term effects into economic evaluations, and statistical approaches to address time-dependent confounding in burden of illness studies.
His work has directly informed national COVID-19 mitigation and testing strategies, vaccination policies against various infectious diseases, as well as national targets for antibiotic prescribing in primary care.
Prior to joining HERC, Koen worked at Public Health England on projects using mathematical, statistical and machine learning approaches to understand and predict the development and health-economic impact of healthcare associated infections and antimicrobial resistance. Before coming to the UK, he obtained his PhD in epidemiology at the University of Groningen where he was also involved in a number of economic evaluations of vaccinations against infectious diseases.
Impact of Delta on viral burden and vaccine effectiveness against new SARS-CoV-2 infections in the UK
Pouwels KB. et al, (2021)
Public preferences for delayed or immediate antibiotic prescriptions in UK primary care: a choice experiment
MORRELL E., (2021), PLoS Medicine
Antibody responses to SARS-CoV-2 vaccines in 45,965 adults from the general population of the United Kingdom
Wei J. et al, (2021), Nature Microbiology
Ct threshold values, a proxy for viral load in community SARS-CoV-2 cases, demonstrate wide variation across populations and over time
Walker AS. et al, (2021), eLife, 10
Impact of vaccination on new SARS-CoV-2 infections in the United Kingdom.
Pritchard E. et al, (2021), Nature medicine